Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication
Medicina Clínica · 2023
DOI: 10.1016/j.medcli.2023.01.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Clínica, 2023. Verfasst von Maria Badarinza und 6 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Internal Medicine Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Romania. Hauptthemen laut MEDLINE: Lymphoma, Sjogren's Syndrome, Parotid Neoplasms, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Internal Medicine Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Romania.
- 2nd Internal Medicine Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Romania. Electronic address: dfodor@umfcluj.ro.
- 2nd Surgical Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Romania.
Zitieren
APA
Badarinza, M., Serban, O., Maghear, L., Pelea, M. A., Rosca, R. I., Fodor, D., & Stancu, B. (2023). Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication. Medicina Clínica. https://doi.org/10.1016/j.medcli.2023.01.023
Vancouver
Badarinza M, Serban O, Maghear L, Pelea MA, Rosca RI, Fodor D, et al. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication. Medicina Clínica. 2023. doi:10.1016/j.medcli.2023.01.023
BibTeX
@article{Badarinza2023,
author = {Badarinza, Maria and Serban, Oana and Maghear, Lavinia and Pelea, Michael Andrei and Rosca, Roxana-Ioana and Fodor, Daniela and Stancu, Bogdan},
title = {Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication},
journal = {Medicina Clínica},
year = {2023},
doi = {10.1016/j.medcli.2023.01.023}
}
EUVIMED